Obesity

Active Research Protocols

  1. 00-CH-0127 – Evaluation of Patients with Endocrine-Related Conditions
  2. 00-CH-0134 – Effects of Metformin on Energy Intake, Energy Expenditure, and Body Weight in Overweight Children with Insulin Resistance
  3. 02-CH-0100 – Supplemental Calcium in Overweight Out-Patients
  4. 02-CH-0309 – The Diagnostic Performance of Screening Tests for the Diagnosis of Cushing's Syndrome
  5. 03-DK-0256 – Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics
  6. 03-HG-0264 – Clinical and Molecular Investigations Into Ciliopathies
  7. 04-CH-0050 – Eating Behavior in Children
  8. 04-HG-0123 – Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics
  9. 06-CH-0038 – Body Heat Content and Dissipation in Obese and Normal Weight Adults
  10. 06-CH-0039 – Pilot Program for Targeted Prevention of Child or Adolescent Weight Gain
  11. 06-DK-0183 – Gene Expression and Release of Inflammatory Mediators in Overweight Subjects Before and After Weight Loss
  12. 06-N-0047 – Reference Values for Plasma Catechols
  13. 07-CH-0126 – Pilot Study of the Metabolic Effects of Betahistine Hydrochloride in Overweight Women
  14. 07-CH-0192 – Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoitic Stem Cell Transplant Recipients
  15. 07-DK-0077 – Study of the Phenotype of Overweight and Obese Adults
  16. 07-DK-0115 – Natural History of Type 2 Diabetes Mellitus in Children and Young Adults
  17. 07-DK-0202 – Thyroid Hormones Homeostasis and Energy Metabolism Changes During Exposure to Cold Temperature in Humans
  18. 08-CH-0085 – Eating Behavior in Adolescents
  19. 08-CH-0139 – Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity
  20. 08-CH-0213 – WAGR Syndrome and Other 11p Contiguous Gene Deletions: Clinical Characterization and Correlation with Genotype
  21. 08-DK-0165 – Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)
  22. 08-H-0108 – Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women
  23. 08-HG-0122 – Patient-Provider Communication and Interaction in a Virtual Clinical Setting
  24. 09-DK-0081 – Selective Reduction of Dietary Carbohydrate Versus Fat: Effects on Metabolism, Endocrine Physiology, Brain Activity and Reward Circuitry
  25. 09-NR-0064 – Brain-Gut Interactions in Overweight and Normal Weight Patients with Chronic Abdominal Pain
  26. 10-DK-0002 – Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
  27. 10-DK-0064 – Effects of Caloric Restriction Alone versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients with Diabetes Mellitus
  28. 10-HG-0076 – Mothers' Thoughts About What Their Children Eat
  29. 11-AA-0028 – Dietary Linoleic Acid Regulation of Omega-3HUFA Metabolism: Satiety and Body Composition Among Overweight Female Subjects
  30. 11-CC-0120 – Stereophotogrammetry of the Torso in Normal Individuals and Patients with Scoliosis, Chest Wall Deformations, or Obesity
  31. 11-CH-0004 – Free Fatty Acids, Body Weight, and Growth Hormone Secretion in Children
  32. 11-CH-0119 – Adrenal Hyperplasia Among Young Women with Polycystic Ovarian Syndrome
  33. 11-CH-0208 – Effects of the Glucocorticoid Antagonist, Mifepristone, on Glucose Intolerance in Obese and Overweight Individuals
  34. 11-CH-0239 – Mood and Insulin Resistance in Adolescents At-Risk for Diabetes
  35. 11-HG-0110 – Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations
  36. 11-HG-0238 – Weight Management Interactions in a Virtual Clinical Environment
  37. 12-CH-0051 – Brain-Derived Neurotrophic Factor in Obesity and Neurocognitive Function
  38. 12-DK-0097 – Energy Expenditure Responses to a Range of Environmental Temperatures around the Thermal Neutral Zone
  39. 12-NR-0195 – Evaluation and Treatment Protocol for Potential Research Participants with Digestive Disorders
  40. 13-CH-0097 – Fat Metabolism and Function Altering Polymorphisms in MC3R
  41. 13-CH-0169 – Effects of Interrupting Sedentary Behavior on Metabolic and Cognitive Outcomes in Children
  42. 13-DK-0090 – Identifying Risk for Diabetes and Heart Disease in Women: A Study of African-American, African and White Federal Employees and Contractors
  43. 13-DK-0136 – A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, 2-Period Crossover Study to Evaluate the Effect of RM-493 on Energy Expenditure in Obese Subjects
  44. 13-H-0123 – An Exploratory Study to Evaluate the Effects of Roflumilast on Insulin Sensitivity and Metabolic Parameters in Prediabetic Overweight and Obese Individuals
  45. 13-H-0130 – Pilot Study of Strength Testing in Overweight Women With or Without Insulin Resistance
  46. 96-CH-0101 – Population Differences in the Insulin Sensitivity, Resting Energy Expenditure, and Body Composition of Overweight Children and Children of Overweight Parents
  47. 98-CH-0111 – Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents with Obesity-Related Comorbid Conditions
  48. 99-DK-0002 – Diabetes and Heart Disease Risk in Blacks
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014